{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T05:10:10Z","timestamp":1727932210239},"reference-count":57,"publisher":"American Society of Consultant Pharmacists","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["sr care pharm"],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:p>The care for patients with heart failure (HF) has evolved greatly over the past decade. While new guidelines have provided more clarity on categorization and staging, and novel agents have been approved for use, there are still questions surrounding the optimal strategies as they relate\n to diet and exercise. Additionally, overall health care costs have increased for patients, driven in part by medication therapy. Given the myriad comorbidities associated with the diagnosis of HF, senior care pharmacists are positioned to positively impact the care for patients with HF, regardless\n of setting. As the guidelines continue to evolve, addressing a wider spectrum of the disease, including iron deficiency, mental health, and pain, so must the pharmacist\u2019s role in caring for patients with HF. Senior care pharmacists engaged in the management of older people with HF must\n be especially attuned to the unique and individualized care each patient needs, offering guidance and education in balancing treatment modalities across all aspects of care. In this three-part series, we will explore a number of areas central to the management of HF. This first section will\n focus on the cost of treatment, pathophysiology, and non-pharmacologic management. Series two and three will address guideline-directed medication therapy and special population management, respectively.<\/jats:p>","DOI":"10.4140\/tcp.n.2024.325","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T04:49:14Z","timestamp":1724474954000},"page":"325-332","source":"Crossref","is-referenced-by-count":0,"title":["Heart Failure in Older People Part 1: Disease State Review and Lifestyle Interventions"],"prefix":"10.4140","volume":"39","author":[{"given":"Jason W.","family":"Lancaster","sequence":"first","affiliation":[{"name":"Northeastern University, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","reference":[{"key":"ref1","first-page":"2023","article-title":"Published August 2022.","volume":"25","year":"2021","journal-title":"Accessed November"},{"journal-title":"An Aging World:","article-title":"US Census Bureau. International Population Reports.","year":"2015","key":"ref2"},{"first-page":"P25","volume-title":"An Aging Nation: The Older Population in the United States; Population Estimates and Projections.","year":"2014","key":"ref3"},{"first-page":"P25","volume-title":"Living Longer: Historical and Projected Life Expectancy in the United States, 1960 to 2060.","year":"2020","key":"ref4"},{"issue":"17","key":"ref5","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology.","volume":"118","year":"2023","journal-title":"Cardiovasc Res"},{"key":"ref6","first-page":"e254","article-title":"Heart disease and stroke statistics\u20142021 update: a report from the American Heart Association.","volume":"143","year":"2021","journal-title":"Circulation"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cardfail.2012.05.007","article-title":"The diversity of heart failure in a hospitalized population: the role of age.","volume":"18","year":"2012","journal-title":"J Cardiovasc Fail"},{"issue":"17","key":"ref8","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.jacc.2018.02.059","article-title":"Domain management approach to heart failure in the geriatric patient: present and future.","volume":"71","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.hfc.2017.02.001","article-title":"Epidemiology, pathophysiology, and prognosis of heart failure in older adults.","volume":"13","year":"2017","journal-title":"Heart Fail Clin"},{"issue":"10","key":"ref10","first-page":"e146","article-title":"Heart disease and stroke statistics\u20142017 update: a report from the American Heart Association.","volume":"135","year":"2017","journal-title":"Circulation"},{"issue":"10159","key":"ref11","first-page":"1789","article-title":"Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"392","year":"2017","journal-title":"Lancet"},{"key":"ref12","first-page":"e895","article-title":"AHA\/ ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"145","year":"2022","journal-title":"Circulation"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jacc.2009.05.013","article-title":"Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.","volume":"54","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"25 pt A","key":"ref14","first-page":"2817","article-title":"Implications of coronary artery disease in heart failure with preserved ejection fraction.","volume":"63","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.","volume":"131","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.","volume":"3","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"48","key":"ref17","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1093\/eurheartj\/ehu193","article-title":"Right heart dysfunction in heart failure with preserved ejection fraction.","volume":"35","year":"2014","journal-title":"Eur Heart J"},{"issue":"37","key":"ref18","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.","volume":"39","year":"2018","journal-title":"Eur Heart J"},{"issue":"17","key":"ref19","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/CIRCULATIONAHA.117.031608","article-title":"Global pulmonary vascular remodeling in pulmonary hypertension associated with heart failure and preserved or reduced ejection fraction.","volume":"137","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ahj.2012.08.014","article-title":"Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.","volume":"164","year":"2012","journal-title":"Am Heart J"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.31083\/j.rcm2302069","article-title":"Interrelation between heart failure with preserved ejection fraction and renal impairment.","volume":"23","year":"2022","journal-title":"Rev Cardiovasc Med"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jacbts.2021.07.010","article-title":"Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction.","volume":"6","year":"2021","journal-title":"JACC Basic Transl Sci"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review.","volume":"329","year":"2023","journal-title":"JAMA"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","article-title":"Research priorities for heart failure with preserved ejection fraction: National Heart, Lung, and Blood Institute Working Group summary.","volume":"141","year":"2020","journal-title":"Circulation"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","article-title":"From systemic inflammation to myocardial fibrosis: the heart failure with preserved ejection fraction paradigm revisited.","volume":"128","year":"2021","journal-title":"Circ Res"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/d41573-022-00158-3","article-title":"Accelerating therapeutic discoveries for heart failure: a new public-private partnership.","volume":"21","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonalactivation in heart failure with reduced ejection fraction.","volume":"14","year":"2017","journal-title":"Nat Rev Cardiol."},{"issue":"27","key":"ref28","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"37","year":"2016","journal-title":"Eur Heart J"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jacc.2020.05.075","article-title":"Heart failure with recovered left ventricular ejection fraction: JACC Scientific Expert Panel.","volume":"76","year":"2020","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and writing committee of the universal definition of heart failure: endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.","volume":"23","year":"2021","journal-title":"Eur J Heart Fail."},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijcard.2013.12.028","article-title":"The annual global economic burden of heart failure.","volume":"171","year":"2014","journal-title":"Int J Cardiol"},{"key":"ref32","first-page":"606","article-title":"American Heart Association Advocacy Coordinating Committee, Council on Arteriosclerosis Thrombosis, Vascular Biology, Council on Cardiovascular Radiology, Intervention, Council on Clinical Cardiology, Council on Epidemiology, Prevention, Stroke Council. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.","volume":"6","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"9","key":"ref33","first-page":"S191","article-title":"Heart failure population health considerations.","volume":"27","year":"2021","journal-title":"Am J Manag Care"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cardfail.2010.01.007","article-title":"Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitus.","volume":"16","year":"2010","journal-title":"J Cardiol Fail"},{"issue":"14","key":"ref35","doi-asserted-by":"crossref","first-page":"e022164","DOI":"10.1161\/JAHA.121.022164","article-title":"Out-of-pocket annual health expenditures and financial toxicity from healthcare costs in patients with heart failure in the United States.","volume":"10","year":"2021","journal-title":"J Am Heart Assoc"},{"year":"2006","key":"ref36"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/oxfordjournals.aje.a114480","article-title":"The diet and 15-year death rate in the seven countries study.","volume":"124","year":"1986","journal-title":"Am J Epidemiol"},{"issue":"36","key":"ref38","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.","volume":"42","year":"2021","journal-title":"Eur Heart J"},{"issue":"21","key":"ref39","doi-asserted-by":"crossref","first-page":"e022930","DOI":"10.1161\/JAHA.121.022930","article-title":"Pragmatic weight management program for patients with obesity and heart failure with preserved ejection fraction.","volume":"10","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"ref40","first-page":"1017","volume":"124","year":"1992","journal-title":"Assessment of patient outcome with the Minnesota Living With Heart Failure Questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group."},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jacc.2018.12.072","article-title":"Impact of exercise rehabilitation on exercise capacity and quality-of-life in heart failure: individual participant meta-analysis.","volume":"73","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"ref42","first-page":"691","article-title":"Exercise-based rehabilitation for heart failure: Cochrane Systematic Review, Meta-Analysis, and Trial Sequential Analysis.","volume":"7","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40798-022-00464-5","article-title":"Exercise training in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis.","volume":"8","year":"2022","journal-title":"Sports Med Open"},{"issue":"13","key":"ref44","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.3390\/ijerph18136761","article-title":"The effects of interval training and continuous training on cardiopulmonary fitness and exercise tolerance of patients with heart failure\u2014a systematic review and meta-analysis.","volume":"18","year":"2021","journal-title":"Int J Environ Res Public Health"},{"journal-title":"Cardiovasc Ther","article-title":"The effects of high-intensity interval training on exercise capacity and prognosis in heart failure and coronary artery disease: a systematic review and meta-analysis.","year":"2022","key":"ref45"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/JCN.0000000000000703","article-title":"Benefits of tai chi exercise among adults with chronic heart failure: a systematic review and meta-analysis.","volume":"35","year":"2020","journal-title":"J Cardiovasc Nurs"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"589267","DOI":"10.3389\/fcvm.2021.589267","article-title":"The effects of tai chi exercise among adults with chronic heart failure: an overview of systematic review and meta-analysis.","volume":"8","year":"2021","journal-title":"Front Cardiovasc Med"},{"journal-title":"Evid Based Complement Alternat Med","article-title":"Effects of cardiac rehabilitation training in patients with heart failure based on traditional Chinese exercise: a systematic review and meta-analysis.","year":"2021","key":"ref48"},{"issue":"9","key":"ref49","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1111\/jgs.17145","article-title":"Frailty implications for exercise participation and outcomes in patients with heart failure.","volume":"69","year":"2021","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cardfail.2006.10.012","article-title":"Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability.","volume":"13","year":"2007","journal-title":"J Card Fail"},{"issue":"6","key":"ref51","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/1474515114541729","article-title":"Isolating the benefits of fluid restriction in patients with heart failure: a pilot study.","volume":"14","year":"2015","journal-title":"Eur J Cardiovasc Nurs"},{"key":"ref52","first-page":"e6817","article-title":"Is fluid restriction needed in heart failure?","volume":"1","year":"2017","journal-title":"Medwave"},{"issue":"10","key":"ref53","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.cardfail.2022.05.015","article-title":"Fluid REStriction in Heart Failure vs Liberal Fluid UPtake: rationale and design of the randomized FRESH-UP study.","volume":"28","year":"2022","journal-title":"J Card Fail"},{"issue":"10333","key":"ref54","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(22)00369-5","article-title":"Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial.","volume":"399","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/JCN.0000000000000880","article-title":"Effect of dietary sodium restriction on the quality of life of patients with heart failure: a systematic review of randomized controlled trials.","volume":"37","year":"2022","journal-title":"J Cardiovasc Nurs"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clnesp.2022.03.032","article-title":"Are the recommendation of sodium and fluid restriction in heart failure patients changing over the past years? A systematic review and meta-analysis.","volume":"49","year":"2022","journal-title":"Clin Nutr ESPEN"},{"issue":"8","key":"ref57","first-page":"e009459","article-title":"Alcohol intake in patients with cardiomyopathy and heart failure: consensus and controversy.","volume":"15","year":"2022","journal-title":"Circ Heart Fail"}],"container-title":["The Senior Care Pharmacist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ascp\/tscp\/2024\/00000039\/00000009\/art00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T04:33:50Z","timestamp":1727930030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.4140\/TCP.n.2024.325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,1]]}},"alternative-id":["2639-9636(20240901)39:9L.325;1-"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2024.325","relation":{},"ISSN":["2639-9636"],"issn-type":[{"type":"print","value":"2639-9636"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}